Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-19-019345

Chief Executive Officer bought 1,530 shares at $6.49 ($9,930)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-03-14 Purchase : show line 1 in the form +1,530 $6.49 $9,930 63,190 D
Open-market purchases · 1,530 sh · avg $6.49 · $9,930
Loading xslF345X03/doc4.xml…